DICE Therapeutics to Host R&D Investor Event on Tuesday, Jun

SOUTH SAN FRANCISCO, Calif., June 13, 2023 -- DICE Therapeutics, Inc. , a biopharmaceutical company leveraging its proprietary DELSCAPE technology platform to build a pipeline of novel oral... | June 13, 2023

Related Keywords

New York , United States , Katie Engleman , Nasdaq , Therapeutics Inc , Dice Therapeutics , Nc Stock Exchange , News , Information , Press Release , Mouth , Han , Pune , 023 , Ice , Iopharmaceutical , Company , Eleveraging , Its , Roprietary , Elscape , Technology , Platform , O , Build , Pipeline , F , Ovel Dice Us23345j1043 ,